Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global Generic Injectables Market Size

The global generic injectables market was valued at USD 56.9 billion in 2024, driven by rising healthcare needs and the introduction of supportive regulatory policies across the globe. The market is expected to grow at a CAGR of 7.80% during the forecast period of 2025-2034, with the values likely to rise from USD 61.6 billion to USD 112.2 billion by 2034.

Global Generic Injectables Market Outlook

  • The market is witnessing a surge in drug approvals of generic injectables by health regulatory agencies. For instance, in April 2024, Gland Pharma Limited received FDA approval for its generic Eribulin Mesylate Injection to treat breast cancer.
  • Recent market trends reveal consolidation via mergers and acquisitions among the key companies to boost market share and expand product portfolios.
  • The oncology segment covers a significant market share due to the rising burden of cancer, which increases the demand for chemotherapy treatments that often require generic injectables.

Global Generic Injectables Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Generic Injectables Market Overview

Generic injectables are similar to their brand-name counterparts in terms of active ingredients, clinical performance, and intended use, among others. They are administered generally through intramuscular or intravenous routes. Generic injectables offer a faster therapeutic effect, higher bioavailability, and can be formulated for slow and sustained release. The rising patent expiration of branded drugs is boosting the market entry of their generic versions, which are typically lower in price and show similar efficacy and safety profiles. The increasing prevalence of chronic diseases and the growing aging population significantly contribute to the rising market demand for generic injectables. Further, supportive policies and initiatives by the government also fuel the market growth by encouraging the use of generic drugs and ensuring faster approval processes for first-time generics.

Global Generic Injectables Market Growth Drivers

Surge in Drug Approvals of Generic Injectables to Affect the Market Landscape Significantly

The market is witnessing a surge in drug approvals of generic injectables by health regulatory agencies such as the United States Food and Drug Corporation (FDA). For instance, in April 2024, an India-based generic injectable manufacturer Gland Pharma Limited received FDA approval for its generic Eribulin Mesylate Injection (0.5 mg/mL single-dose vial) to treat breast cancer. The product, which Gland Pharma co-developed with a research-oriented pharmaceutical product development company Orbicular Pharmaceutical Technologies Private Ltd, is expected to be the first generic intravenous drug for this condition in the United States. The rise in approval of new generic injectables, accelerated by the presence of a supportive regulatory framework, is anticipated to influence the market dynamics.

Launch of New Products to Meet Rising Generic Injectables Market Demand

In March 2024, Meitheal Pharmaceuticals, Inc., a generic injectables company based in Chicago, announced recent business progress to support a sustainable drug supply in the United States following its generic injectables portfolio expansion in September 2023. The company is preparing to launch up to 20 new products in 2024 spread across various therapeutic areas and has invested over USD 100 million in generic research and development over the past six years. Additionally, the generic injectables manufacturer recently launched multiple presentations of bupivacaine hydrochloride injection (an anesthetic used for surgical, therapeutic, diagnostic, and obstetrical procedures). The rising introduction of sustainably manufactured and priced generic injectables is poised to augment market demand.

Generic Injectables Market by Container

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Generic Injectables Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Key Trends Impact
Rising Technological Advancements in Manufacturing Processes The rising advancements in technology are allowing manufacturers to improve the efficiency and scalability of generic injectable production. Integration of innovations such as automation and data analytics in manufacturing processes helps in reduce costs and enhance quality control. This leads to the development of more reliable and consistent products, enabling companies to meet stringent regulatory standards and contributing to the overall market growth.
Increased Strategic Mergers and Acquisitions Recent market trends reveal consolidation via mergers and acquisitions among the key companies to boost market share and expand product portfolios. This strategy enables companies to enter new markets, optimize their supply chains, and increase R&D capabilities by sharing resources and expertise. Such strategic partnerships drive innovation and also elevate the generic injectables market value.
Growing Focus on Sterile Injectables The increasing focus on sterile injectables is in response to the need for higher safety standards in medication administration. This trend has led to substantial investments in cleanroom technology and quality control systems. The growing emphasis on sterile injectables is likely to improve patient safety and increase the demand for generic injectables in clinical settings.
Expansion into Emerging Markets Many generic injectables manufacturers are increasingly expanding their presence into emerging markets such as Asia, Latin America, and Africa. These regions offer significant growth opportunities due to rising healthcare needs and increasing investment in healthcare infrastructure. The rising introduction of international companies in these emerging economies is poised to increase access to affordable injectables in underserved areas, thereby contributing to improved patient outcomes.

Global Generic Injectables Market Segmentation

Market Breakup by Product Type

  • Large Molecule Injectables
    • Monoclonal Antibodies (mAbs)
    • Insulin
    • Others
  • Small Molecule Injectables

Market Breakup by Container Type

  • Vials
  • Premix
  • Prefilled Syringes
  • Ampoules
  • Others

Market Breakup by Application

  • Oncology
  • Cardiovascular
  • CNS
  • Infectious Diseases
  • Autoimmune Disorders
  • Others

Market Breakup by Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others

Market Breakup by Distribution Channel

  • Hospital
  • Retail Pharmacy
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Generic Injectables Market Share

Oncology Segment Leads Market Share by Application

Based on the application, the market is segmented into oncology, cardiovascular, CNS, infectious diseases, and autoimmune disorders, among others. The oncology segment covers a significant market share due to the rising burden of cancer, which increases the demand for chemotherapy treatments that often require generic injectables. Generic carboplatin and cisplatin are platinum-based, injectable chemotherapeutic drugs that are commonly used in curative regimens and combination therapies. Further, cardiovascular and Infectious segments also hold a high market value owing to its efficacy and rapid onset of action of various generic injectables in treating cardiovascular conditions and infectious diseases.

Market Segmentation Based on Container Type is Anticipated to Witness Substantial Growth

Container types available in the market include vials, premix, prefilled syringes, and ampoules, among others. The market share is driven by the rising need for reliable and cost-effective containers that are compatible with a wide range of drug formulations. Vial is the traditional container type and is commonly used due to its affordability, particularly for high-volume production. Additionally, the ease of manufacture and the simplicity of design make it a preferred choice for many pharmaceutical companies.

Generic Injectables Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Generic Injectables Market Analysis by Region

Based on the region, the market covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, with each region contributing to the overall dynamics of the market. North America holds the largest market share, valued at USD 33 billion in 2023, which can be attributed to the increasing burden of chronic diseases and the growing aging population. For instance, the American Cancer Society’s annual cancer statistics report estimated that new cancer cases will surpass 2 million in the United States in 2024, which indicates the need for effective and affordable generic drugs including generic injectables.

Europe also holds a high market value, with the market size estimated to be USD 13.5 billion in 2023, owing to the rising healthcare needs and the presence of a favorable regulatory environment. Asia Pacific is projected to witness exponential growth driven by increased government initiatives that promote the uptake and manufacture of generic injectables.

Leading Players in the Global Generic Injectables Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Pfizer Inc.

The global pharmaceutical giant Pfizer has a strong presence in the generic injectables market. Acquired in 2015, its subsidiary Hospira specializes in injectable drugs and infusion technologies.

Teva Pharmaceutical Industries Ltd.

Headquartered in Israel, Teva is one of the largest generic drug manufacturers in the world. The company offers a range of generic injectable products in multiple therapeutic areas including pain management and oncology.

Baxter

Baxter International Inc. is a global leader in generic injectables, specializing in anesthesia and critical care domain. The company is popular for its innovative delivery systems and premixed injectable drugs.

Novartis Pharmaceuticals Corporation

In October 2023, Novartis completed the Spin-off of its generics and biosimilars business, Sandoz, which is a key player in the generic injectables market, focusing on therapeutic areas such as oncology, immunology, and endocrinology.

Other players in the market include Fresenius SE & Co. KGaA, Endo, Inc., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Sagent Pharmaceuticals, Viatris Inc. (Mylan N.V.), Biocon, Sanofi, Lupin, Aurobindo Pharma Limited, and Sun Pharmaceutical Industries Ltd, among others.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Container Type
  • Application
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Product Type
  • Large Molecule Injectables
  • Small Molecule Injectables
Breakup by Container Type
  • Vials
  • Premix
  • Prefilled Syringes
  • Ampoules
  • Others
Breakup by Application
  • Oncology
  • Cardiovascular
  • CNS
  • Infectious Diseases
  • Autoimmune Disorders
  • Others
Breakup by Route of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others
Breakup by Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Others 
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Baxter.
  • Novartis Pharmaceuticals Corporation
  • Fresenius SE & Co. KGaA
  • Endo, Inc.
  • Hikma Pharmaceuticals PLC
  • Dr.Reddy’s Laboratories Ltd.
  • Sagent Pharmaceuticals
  • Viatris Inc.
  • Biocon
  • Sanofi
  • Lupin.
  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Ltd.  

Key Questions Answered in the Global Generic Injectables Market Report

  • What was the global generic injectables market value in 2023?
  • What is the global generic injectables market forecast outlook for 2025-2034?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on product type?
  • What is the market breakup based on container type?
  • What are the major applications areas of generic injectables?
  • What is the market breakup by route of administration?
  • What are the distribution channels in the market?
  • What are the major factors aiding the global generic injectables market demand? 
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • How do the prevalence and incidence of chronic diseases affect the market landscape?
  • What are the major global generic injectables market trends?
  • How does the rise in the geriatric population impact the market size?
  • Which product type will dominate the market share? 
  • Which application area is expected to have a high market value in the coming years?
  • Which container type will experience the highest demand in the market segment?
  • Which distribution channel will contribute significantly to the market growth?
  • Which route of administration is poised to lead the market share?
  • Who are the key players involved in the generic injectables market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Selected Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Selected Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124